This page contains a Flash digital edition of a book.
IMPORTANT ADVANCES IN NUCLEAR MEDICINE Despite the ability of magnetic resonance imaging (MRI) to demonstrate physiology without radiation burden, nuclear medicine remains the modality of choice for capturing functional information. Since the introduction of 2-dimensional imaging to nuclear medicine, there has been a steady improvement in gamma camera technology due to the development of equipment and computer software. Planar imaging has been highly valuable for a wide range of pathology, although there have always been limitations such as the highly specific tracer uptake (no anatomical landmarks) associated with colloid imaging for sentinel nodes12 in technology to improve imaging.


. This type of difficulty has driven the advancement


SPECT was introduced in the mid to late 1980s to produce cross-sectional images of radionuclide uptake, allowing improved specificity, due in part to the ability of SPECT to differentiate between overlying structures. The popularity of SPECT led to the introduction of dual-headed gamma cameras and the technique became the standard for some investigations. Methods were developed to correct for radionuclide attenuation within the patient (eg Gd-153) to help quantify uptake and improve image quality.


SPECT/CT is the most recent notable advancement in nuclear medicine technology and is already popular for certain techniques. SPECT (emission data) is combined with CT (transmission data) on a single scanner gantry (Figure 2)13 fused data set of images showing functional and anatomical data.


to provide an accurately


The CT component of SPECT/CT has three distinct roles: attenuation correction (AC), lesion localisation and diagnosis. There are two different types of CT system available to support these roles: low-resolution (most suitable for AC) and diagnostic quality with the same functionality as a stand-alone CT scanner.


ROLES OF SPECT/CT IN LYMPHOSCINTIGRAPHY


Attenuation Correction (AC) Photons emanating from radioactive foci deep within the body are susceptible to absorption by the body before they can be detected by the gamma camera. Consequently, deep sited foci, such as a sentinel node, can go undetected in both planar and SPECT imaging negatively affecting the sensitivity and specificity of the diagnostic procedure.


CT (low-dose) can generate an attenuation map that, when applied to SPECT data, can correct for photon attenuation. This technique is now commonplace for certain patients and techniques in SPECT imaging; indeed, AC has been shown to have value for obese patients undergoing lymphoscintigraphy, with improved identification and a greater number of nodes being marked as sentinel.14


Lesion localisation and diagnosis Whether using low-dose CT or diagnostic quality CT, foci of radionuclide


GAMMA CAMERA 2


Figure 2. SPECT-CT Unit: CT Studies with SPECT. CT = computed tomography; SPECT = single photon emis- sion CT. Courtesy of Siemens press pictures http://www.siemens.com/press/pool/de/pp_med/2005/ sc_upload_file_mednm200504048_03_300dpi_1456207.jpg Accessed January 201113. Annotated by the authors.


SCANNER


CT


GAMMA CAMERA 1


33 2011


IMAGING & ONCOLOGY


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72